Foley Hoag LLP advised Genialis on the deal. Genialis, a computational precision medicine company, announced its $13M Series A financing led by Debiopharm Innovatoin Fund and Taiwania...
You must be a Standard 1 Year member to access this content.
Foley Hoag LLP advised Alloy Therapeutics on the deal. Alloy Therapeutics, a biotechnology ecosystem company, announced a $42 million Series D financing round led by its existing...
You must be a Standard 1 Year member to access this content.
Foley Hoag advised H.I.G. BioHealth Partners and Accelmed Partners on the deal. H.I.G. BioHealth Partners and Accelmed Partners acted as new investors and co-leads in the...
You must be a Standard 1 Year member to access this content.
Foley Hoag advised Alcyone Therapeutics on the deal. Alcyone Therapeutics, a Lowell, Massachusetts-based biotechnology company pioneering next-generation precision central nervous system (CNS) therapies, closed $23 million in...
You must be a Standard 1 Year member to access this content.
Foley Hoag LLP advised Alloy Therapeutics on the deal. Alloy Therapeutics announced a $75 million Series C Financing. Proceeds from the Series C financing will support the...
You must be a Standard 1 Year member to access this content.
